Estée Lauder Companies
EL
$83.90
-1.15%
Estée Lauder is a global leader in the prestige beauty market, operating across skin care (49% of fiscal 2025 sales), makeup (29%), fragrance (17%), and hair care (5%) with iconic brands like Estée Lauder, Clinique, M.A.C, and La Mer. The company holds a dominant competitive position in the premium beauty segment, leveraging a diversified brand portfolio and extensive global distribution across 150+ countries. Currently, the investor narrative centers on the company's independent turnaround strategy after merger talks with Puig ended, with attention on its ability to restore growth in a challenging luxury demand environment, particularly in Asia-Pacific and travel retail.…
EL
Estée Lauder Companies
$83.90
Related headlines
Investment Opinion: Should I buy EL Today?
Rating: Hold. The thesis is that Estée Lauder is a deeply undervalued turnaround play with strong free cash flow and a dominant brand portfolio, but weak profitability and macro headwinds justify a cautious stance until consistent earnings improvement is evident. The analyst consensus is Buy with an average target of $95.54, implying 19% upside, but the stock's persistent downtrend and near 52-week low suggest the market is pricing in significant risks.
Supporting Evidence: The trailing PS ratio of 2.04 is an 18% discount to the industry average of 2.5 and well below the 5-year average of ~4.5. Revenue grew 4.6% YoY in Q3, signaling a potential recovery. Free cash flow of $1.285 billion provides a 4.4% yield relative to market cap. However, net margin of 2.4% and negative ROE of -29.3% highlight profitability challenges. The forward PE of 25.3x based on estimated EPS of $4.90 is elevated, but the PEG ratio of 0.07 suggests the market expects strong earnings growth.
Risks & Conditions: The biggest risks are failure to sustain revenue growth, margin compression, and macro headwinds in Asia-Pacific. This Hold would upgrade to Buy if the company reports two consecutive quarters of positive net income and gross margins stabilize above 72%. It would downgrade to Sell if revenue growth turns negative again or if the stock breaks below the 52-week low of $66.22. Overall, Estée Lauder appears undervalued relative to its historical PS multiple but fairly valued given its current profitability. The valuation discount is justified by the earnings volatility, making it a speculative value play rather than a clear bargain.
Sign up to view all
EL 12-Month Price Forecast
Estée Lauder is at a critical juncture. The return to revenue growth and strong free cash flow provide a foundation for recovery, but weak profitability and high leverage keep the stock in a high-risk category. The valuation is attractive on a historical basis, but the market is right to be skeptical until margins improve consistently. The base case of modest growth and stable margins is most likely, leading to a neutral stance. An upgrade to bullish would require two consecutive quarters of positive net income and gross margins above 72%. A downgrade to bearish would occur if revenue growth turns negative or the stock breaks below $66.22.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Estée Lauder Companies's 12-month outlook, with a consensus price target around $95.85 and implied upside of +14.2% versus the current price.
Average Target
$95.85
0 analysts
Implied Upside
+14.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$70 - $125
Analyst target range
The stock is covered by 26 analysts, with a consensus recommendation of 'Buy' (mean rating of 2.36 on a 1-5 scale, where 1 is Strong Buy). The average target price is $95.54, implying approximately 19% upside from the current price of $80.29. The distribution shows a bullish lean, with several major firms maintaining Buy or Overweight ratings (e.g., Citigroup, JP Morgan). The target range spans from a low of $70.00 to a high of $125.00. The high target of $125.00 assumes a successful turnaround with margin expansion and revenue acceleration, potentially driven by new product launches and market share gains. The low target of $70.00 prices in continued weakness in Asia-Pacific, competitive pressure, and potential margin compression. Recent ratings actions show stability, with no major downgrades or upgrades in the last three months, suggesting analysts are waiting for clearer signs of recovery. The wide spread between low and high targets ($55) indicates high uncertainty about the company's future performance, which is typical for a company undergoing a strategic transformation.
Drowning in data?
Find the real signal!
Bulls vs Bears: EL Investment Factors
Estée Lauder presents a classic turnaround story with both compelling value and significant risk. On the bull side, the return to revenue growth, strong free cash flow, and deeply discounted valuation relative to history and peers suggest that the worst may be priced in. The analyst consensus Buy rating with 19% upside adds further support. However, the bear case is equally strong: weak profitability, negative ROE, high leverage, and a persistent downtrend near 52-week lows indicate that the market is skeptical about the sustainability of the recovery. The single most important tension is whether the company can translate its modest revenue growth into meaningful margin expansion and consistent profitability. If it can, the stock could re-rate significantly; if not, further downside toward the 52-week low of $66.22 is likely. Currently, the bearish evidence is slightly more compelling given the earnings volatility and macro headwinds, but the valuation discount provides a margin of safety for patient investors.
Bullish
- Return to Revenue Growth: Q3 fiscal 2026 revenue grew 4.6% YoY to $3.712 billion, marking a return to growth after several quarters of decline. This signals that the company's turnaround initiatives may be gaining traction, supported by strength in skin care ($1.856B) and makeup ($1.072B).
- Analyst Consensus Buy with 19% Upside: 26 analysts rate the stock a Buy with an average target of $95.54, implying 19% upside from the current $80.29. The high target of $125 suggests significant potential if the turnaround succeeds.
- Strong Free Cash Flow Generation: TTM free cash flow is $1.285 billion, providing a cushion for dividends and capex. Operating cash flow of $412 million in Q3 easily covered capex of $102 million, indicating financial flexibility.
- Valuation Near Historical Lows: The trailing PS ratio of 2.04 is well below the 5-year average of ~4.5 and represents an 18% discount to the industry average of 2.5. This suggests pessimism is priced in, offering a potential entry point for value investors.
Bearish
- Weak Profitability and Negative ROE: Net margin in Q3 was just 2.4%, down from 4.5% a year ago, and ROE is deeply negative at -29.3%. The company has reported net losses in three of the last four quarters, indicating persistent earnings volatility.
- High Debt-to-Equity Ratio: Debt-to-equity stands at 2.44, reflecting significant leverage. While current ratio of 1.30 provides some liquidity, the high debt load increases financial risk, especially if earnings do not recover.
- Sustained Downtrend and Near 52-Week Low: The stock is down 7.5% over the past year and trades at just 24% of its 52-week range, near the low of $66.22. The 1-year downtrend remains intact, and the stock has underperformed the S&P 500 by 23.9% over the past year.
- Macro Headwinds in Asia-Pacific and Travel Retail: The company generates 32% of revenue from Asia-Pacific and a significant portion from travel retail, both of which face headwinds from slower luxury demand and geopolitical tensions. This exposure limits the pace of recovery.
EL Technical Analysis
The stock is in a sustained downtrend, with a 1-year price change of -7.5% and a 52-week range of $66.22 to $121.64. The current price of $80.29 sits at just 24% of the 52-week range, near the lows, indicating persistent bearish pressure and suggesting the market is pricing in significant headwinds. This positioning near the low end of the range often signals either a value opportunity or a falling knife, depending on fundamental catalysts. Short-term momentum shows a mixed picture: the 1-month change is -3.6%, while the 3-month change is +3.2%, indicating a slight recovery from the March lows. However, the 1-year downtrend remains intact, and the divergence between the short-term bounce and long-term decline could signal a temporary pullback rather than a reversal. The relative strength index (RSI) is not provided, but the volume data shows an average of 1.43 million shares, with recent spikes suggesting active trading. The 52-week low of $66.22 serves as key support, while resistance is at the 52-week high of $121.64. A breakout above $121.64 would signal a major trend reversal, while a breakdown below $66.22 could accelerate selling. The stock's beta of 1.26 indicates 26% more volatility than the S&P 500, meaning larger price swings and higher risk for position sizing.
Beta
1.26
1.26x market volatility
Max Drawdown
-43.8%
Largest decline past year
52-Week Range
$66-$122
Price range past year
Annual Return
-10.1%
Cumulative gain past year
| Period | EL Return | S&P 500 |
|---|---|---|
| 1m | +1.7% | +0.2% |
| 3m | +5.8% | +3.7% |
| 6m | -27.2% | +8.0% |
| 1y | -10.1% | +18.2% |
| ytd | -21.4% | +9.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
EL Fundamental Analysis
Revenue in the most recent quarter (Q3 fiscal 2026, ended March 31, 2026) was $3.712 billion, up 4.6% year-over-year, marking a return to growth after several quarters of decline. However, the multi-quarter trend shows uneven performance: Q2 fiscal 2026 revenue was $4.238 billion (flat vs. prior year), while Q1 fiscal 2026 was $3.481 billion (up 3.6% YoY). The growth is driven by skin care ($1.856 billion) and makeup ($1.072 billion), while fragrance ($628 million) and hair care ($128 million) contribute less. The revenue growth is modest and suggests a gradual recovery, but the company still faces headwinds in Asia-Pacific and travel retail. Profitability remains weak: net income in Q3 fiscal 2026 was $89 million, with a net margin of just 2.4%, down from 4.5% in the prior-year quarter. Gross margin was 71.0%, stable but slightly compressed from 74.9% a year ago. The company has reported net losses in three of the last four quarters (including a -$546 million loss in Q4 fiscal 2025), indicating significant earnings volatility. Operating margin was 9.6%, recovering from negative levels in prior quarters, but still well below historical norms. The balance sheet shows moderate leverage: debt-to-equity is 2.44, and the current ratio is 1.30, indicating adequate liquidity. Free cash flow (TTM) is $1.285 billion, providing some cushion for dividends and capex. However, ROE is deeply negative at -29.3%, reflecting the impact of recent losses on equity. The company generated $412 million in operating cash flow in Q3 fiscal 2026, enough to cover capex of $102 million, but the high debt load (debt-to-equity of 2.44) raises financial risk, especially if earnings do not recover.
Quarterly Revenue
$3.7B
2026-03
Revenue YoY Growth
+4.6%
YoY Comparison
Gross Margin
71.0%
Latest Quarter
Free Cash Flow
$1.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is EL Overvalued?
Since net income is negative on a trailing twelve-month basis (TTM EPS of -$0.04), the price-to-earnings (PE) ratio is not meaningful. Therefore, we use the price-to-sales (PS) ratio as the primary valuation metric. The trailing PS ratio is 2.04, while the forward PS ratio (based on estimated revenue of $17.3 billion) is approximately 1.68. The gap between trailing and forward PS suggests the market expects revenue growth to improve, which aligns with the recent 4.6% YoY increase. Compared to the household & personal products industry average PS ratio of approximately 2.5 (based on sector data), Estée Lauder trades at a 18% discount (2.04 vs. 2.5). This discount may be justified by the company's weak profitability and negative net income, as peers typically have higher margins. Historically, Estée Lauder's PS ratio has ranged from 1.5 to 30 over the past five years, with the current level near the low end of that range. The stock's trailing PS of 2.04 is well below the 5-year average of around 4.5, indicating that the market is pricing in significant pessimism. This could represent a value opportunity if the company's turnaround gains traction, but it also reflects the risk of further deterioration.
PE
-25.7x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 28x~169x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
184.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Estée Lauder's primary financial risk is its weak profitability and high leverage. Net margin in Q3 fiscal 2026 was just 2.4%, down from 4.5% a year ago, and the company has reported net losses in three of the last four quarters, including a -$546 million loss in Q4 fiscal 2025. ROE is deeply negative at -29.3%, reflecting the erosion of shareholder equity. Debt-to-equity is 2.44, indicating significant leverage that could strain cash flows if earnings deteriorate further. While free cash flow of $1.285 billion provides some cushion, the high debt load increases financial risk, especially if interest rates remain elevated.
Market & Competitive Risks: The stock's beta of 1.26 indicates 26% more volatility than the market, making it sensitive to macro downturns. The trailing PS ratio of 2.04, while below historical averages, could compress further if revenue growth stalls. The company faces intense competition from L'Oréal and Coty in the prestige beauty space, and the recent termination of merger talks with Puig removes a potential catalyst. Regulatory risks include potential tariffs on imports from Asia, which could impact margins. The stock's 1-year relative strength of -23.9% versus the S&P 500 highlights persistent underperformance.
Worst-Case Scenario: In a severe downturn, continued weakness in Asia-Pacific and travel retail could lead to further revenue declines and margin compression. If the company reports another loss and cuts its dividend, the stock could fall to its 52-week low of $66.22, representing a 17.5% decline from the current price. In an extreme scenario, if the turnaround fails and debt covenants are breached, the stock could test the analyst low target of $70.00, implying a 12.8% downside. The maximum drawdown of -43.79% from the 52-week high of $121.64 to the low of $66.22 illustrates the potential for significant losses.
FAQ
The primary risks are financial, competitive, and macro. Financially, the company has high leverage (debt-to-equity of 2.44) and weak profitability (net margin of 2.4%), which could lead to dividend cuts or covenant breaches. Competitively, L'Oréal and Coty pose threats in the prestige beauty space. Macro risks include exposure to Asia-Pacific (32% of revenue) and travel retail, which are sensitive to consumer spending and geopolitical tensions. The stock's beta of 1.26 also means higher volatility than the market.
The 12-month outlook is mixed. The base case (50% probability) sees the stock trading in the $80-$95 range, with modest revenue growth and stable margins. The bull case (25% probability) targets $95-$125, driven by a successful turnaround and margin expansion. The bear case (25% probability) sees the stock falling to $66-$80 if revenue growth stalls or margins compress. The most likely scenario is the base case, with the stock hovering near current levels until clearer signs of recovery emerge.
Based on the price-to-sales ratio, EL appears undervalued relative to its history and peers. The trailing PS of 2.04 is well below the 5-year average of ~4.5 and the industry average of 2.5. However, this discount is justified by the company's weak profitability and negative net income. The forward PE of 25.3x based on estimated EPS of $4.90 is elevated, but the PEG ratio of 0.07 suggests the market expects strong earnings growth. Overall, the stock is undervalued on a sales basis but fairly valued on an earnings basis given the current margin profile.
Estée Lauder presents a high-risk, high-reward opportunity. The stock trades at a PS ratio of 2.04, an 18% discount to the industry average, and analysts see 19% upside to the average target of $95.54. However, the company's weak profitability (net margin of 2.4%) and negative ROE (-29.3%) make it a speculative turnaround play. For investors with a long-term horizon and high risk tolerance, the current valuation near historical lows could offer significant upside if the turnaround succeeds. However, conservative investors may prefer to wait for consistent earnings improvement before buying.
EL is better suited for long-term investment given its turnaround nature and high volatility (beta of 1.26). Short-term trading is risky due to the stock's downtrend and sensitivity to quarterly earnings. The company's strong brand portfolio and free cash flow provide a foundation for long-term recovery, but investors should be prepared for a holding period of at least 12-24 months. The dividend yield of 2.1% offers some income, but the payout ratio of -54.5% (based on negative EPS) suggests the dividend is not secure.
